SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Extracellular histones disarrange vasoactive mediators release through a COX-NOS interaction in human endothelial cells.

Pérez-Cremades, D; Bueno-Betí, C; García-Giménez, JL; Ibañez-Cabellos, JS; Hermenegildo, C; Pallardó, FV; Novella, S (2017) Extracellular histones disarrange vasoactive mediators release through a COX-NOS interaction in human endothelial cells. J Cell Mol Med, 21 (8). pp. 1584-1592. ISSN 1582-4934 https://doi.org/10.1111/jcmm.13088
SGUL Authors: Bueno Beti, Carlos

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (533kB) | Preview

Abstract

Extracellular histones are mediators of inflammation, tissue injury and organ dysfunction. Interactions between circulating histones and vascular endothelial cells are key events in histone-mediated pathologies. Our aim was to investigate the implication of extracellular histones in the production of the major vasoactive compounds released by human endothelial cells (HUVECs), prostanoids and nitric oxide (NO). HUVEC exposed to increasing concentrations of histones (0.001 to 100 μg/ml) for 4 hrs induced prostacyclin (PGI2) production in a dose-dependent manner and decreased thromboxane A2 (TXA2) release at 100 μg/ml. Extracellular histones raised cyclooxygenase-2 (COX-2) and prostacyclin synthase (PGIS) mRNA and protein expression, decreased COX-1 mRNA levels and did not change thromboxane A2 synthase (TXAS) expression. Moreover, extracellular histones decreased both, eNOS expression and NO production in HUVEC. The impaired NO production was related to COX-2 activity and superoxide production since was reversed after celecoxib (10 μmol/l) and tempol (100 μmol/l) treatments, respectively. In conclusion, our findings suggest that extracellular histones stimulate the release of endothelial-dependent mediators through an up-regulation in COX-2-PGIS-PGI2 pathway which involves a COX-2-dependent superoxide production that decreases the activity of eNOS and the NO production. These effects may contribute to the endothelial cell dysfunction observed in histone-mediated pathologies.

Item Type: Article
Additional Information: © 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: endothelial cells, extracellular histones, nitric oxide, prostanoids, vascular mediators, Celecoxib, Cyclic N-Oxides, Cyclooxygenase 1, Cyclooxygenase 2, Cytochrome P-450 Enzyme System, Dose-Response Relationship, Drug, Epoprostenol, Gene Expression Regulation, Histones, Human Umbilical Vein Endothelial Cells, Humans, Intramolecular Oxidoreductases, Nitric Oxide, Nitric Oxide Synthase Type III, Primary Cell Culture, RNA, Messenger, Signal Transduction, Spin Labels, Superoxides, Thromboxane A2, Thromboxane-A Synthase, Humans, Superoxides, Nitric Oxide, Spin Labels, Cyclic N-Oxides, Cytochrome P-450 Enzyme System, Intramolecular Oxidoreductases, Thromboxane-A Synthase, Epoprostenol, Thromboxane A2, Histones, RNA, Messenger, Signal Transduction, Gene Expression Regulation, Dose-Response Relationship, Drug, Cyclooxygenase 1, Cyclooxygenase 2, Nitric Oxide Synthase Type III, Human Umbilical Vein Endothelial Cells, Primary Cell Culture, Celecoxib, extracellular histones, endothelial cells, vascular mediators, nitric oxide, prostanoids, 0304 Medicinal and Biomolecular Chemistry, 0601 Biochemistry and Cell Biology, 1103 Clinical Sciences, Biochemistry & Molecular Biology
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: J Cell Mol Med
ISSN: 1582-4934
Language: eng
Dates:
DateEvent
August 2017Published
28 February 2017Published Online
13 December 2016Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 28244682
Web of Science ID: WOS:000406833000014
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/111982
Publisher's version: https://doi.org/10.1111/jcmm.13088

Actions (login required)

Edit Item Edit Item